Clinical Trials Directory

Trials / Completed

CompletedNCT01366885

Vitamin D to Prevent Autism in Newborn Siblings

Study of Vitamin D to Prevent Autism in Newborn Siblings

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
Female
Age
20 Years – 44 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether by administering vitamin D to mothers who already have at least one child with autism and who are pregnant, that the vitamin D will prevent the recurrence of autism in the newborn sibling.

Detailed description

The incidence of autism is increasing. Also, women of childbearing age are increasingly found to be insufficient/deficient in vitamin D. Vitamin D is a neurohormone which is important for development of the child, especially of the child's brain. The primary source of vitamin D is from the sun through one's skin. People have been avoiding the sun because of skin cancer, because of increasing Television watching, computer viewing and wearing clothes that cover most of the body. This approach will study whether making the pregnant mother, whose child is at risk for autism because of a previous child with autism, replete with vitamin D will prevent that recurrence of autism in the newborn sibling.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D35000 IU D3 capsule oral/day for entire pregnancy. 7000 IU D3/day during breastfeeding. If not breast feeding, baby gets 400 IU D3/day. Baby increased to 1000 IU D3/day at one year of age.

Timeline

Start date
2008-02-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2011-06-06
Last updated
2016-06-14
Results posted
2016-06-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01366885. Inclusion in this directory is not an endorsement.